221 related articles for article (PubMed ID: 33190594)
1. The therapeutic potential of exosomal miR-22 for cervical cancer radiotherapy.
Konishi H; Hayashi M; Taniguchi K; Nakamura M; Kuranaga Y; Ito Y; Kondo Y; Sasaki H; Terai Y; Akao Y; Ohmichi M
Cancer Biol Ther; 2020 Dec; 21(12):1128-1135. PubMed ID: 33190594
[TBL] [Abstract][Full Text] [Related]
2. Exosomal microRNAs: novel players in cervical cancer.
Nahand JS; Vandchali NR; Darabi H; Doroudian M; Banafshe HR; Moghoofei M; Babaei F; Salmaninejad A; Mirzaei H
Epigenomics; 2020 Sep; 12(18):1651-1660. PubMed ID: 32957811
[TBL] [Abstract][Full Text] [Related]
3. Exosomal miR-9 inhibits angiogenesis by targeting MDK and regulating PDK/AKT pathway in nasopharyngeal carcinoma.
Lu J; Liu QH; Wang F; Tan JJ; Deng YQ; Peng XH; Liu X; Zhang B; Xu X; Li XP
J Exp Clin Cancer Res; 2018 Jul; 37(1):147. PubMed ID: 30001734
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells.
Kia V; Paryan M; Mortazavi Y; Biglari A; Mohammadi-Yeganeh S
J Cell Biochem; 2019 Apr; 120(4):5666-5676. PubMed ID: 30335891
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-22 enhances radiosensitivity in cervical cancer cell lines via direct inhibition of c-Myc binding protein, and the subsequent reduction in hTERT expression.
Nakamura M; Hayashi M; Konishi H; Nunode M; Ashihara K; Sasaki H; Terai Y; Ohmichi M
Oncol Lett; 2020 Mar; 19(3):2213-2222. PubMed ID: 32194719
[TBL] [Abstract][Full Text] [Related]
6. Exosomal miR-99a-5p is elevated in sera of ovarian cancer patients and promotes cancer cell invasion by increasing fibronectin and vitronectin expression in neighboring peritoneal mesothelial cells.
Yoshimura A; Sawada K; Nakamura K; Kinose Y; Nakatsuka E; Kobayashi M; Miyamoto M; Ishida K; Matsumoto Y; Kodama M; Hashimoto K; Mabuchi S; Kimura T
BMC Cancer; 2018 Nov; 18(1):1065. PubMed ID: 30396333
[TBL] [Abstract][Full Text] [Related]
7. Exosome-mediated delivery of miR-204-5p inhibits tumor growth and chemoresistance.
Yao S; Yin Y; Jin G; Li D; Li M; Hu Y; Feng Y; Liu Y; Bian Z; Wang X; Mao Y; Zhang J; Wu Z; Huang Z
Cancer Med; 2020 Aug; 9(16):5989-5998. PubMed ID: 32618144
[TBL] [Abstract][Full Text] [Related]
8. Macrophages derived exosomes deliver miR-223 to epithelial ovarian cancer cells to elicit a chemoresistant phenotype.
Zhu X; Shen H; Yin X; Yang M; Wei H; Chen Q; Feng F; Liu Y; Xu W; Li Y
J Exp Clin Cancer Res; 2019 Feb; 38(1):81. PubMed ID: 30770776
[TBL] [Abstract][Full Text] [Related]
9. HIV-1-infected cell-derived exosomes promote the growth and progression of cervical cancer.
Li H; Chi X; Li R; Ouyang J; Chen Y
Int J Biol Sci; 2019; 15(11):2438-2447. PubMed ID: 31595161
[No Abstract] [Full Text] [Related]
10. Upregulated exosomal miR-221/222 promotes cervical cancer via repressing methyl-CpG-binding domain protein 2.
Pan ZX; Zhang XY; Chen SR; Li CZ
Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3645-3653. PubMed ID: 31114989
[TBL] [Abstract][Full Text] [Related]
11. Hypoxic tumour cell-derived exosomal miR-340-5p promotes radioresistance of oesophageal squamous cell carcinoma via KLF10.
Chen F; Xu B; Li J; Yang X; Gu J; Yao X; Sun X
J Exp Clin Cancer Res; 2021 Jan; 40(1):38. PubMed ID: 33485367
[TBL] [Abstract][Full Text] [Related]
12. Exosome-mediated transfer of miR-222 is sufficient to increase tumor malignancy in melanoma.
Felicetti F; De Feo A; Coscia C; Puglisi R; Pedini F; Pasquini L; Bellenghi M; Errico MC; Pagani E; Carè A
J Transl Med; 2016 Feb; 14():56. PubMed ID: 26912358
[TBL] [Abstract][Full Text] [Related]
13. Tumor-Secreted Exosomal miR-222 Promotes Tumor Progression via Regulating P27 Expression and Re-Localization in Pancreatic Cancer.
Li Z; Tao Y; Wang X; Jiang P; Li J; Peng M; Zhang X; Chen K; Liu H; Zhen P; Zhu J; Liu X; Liu X
Cell Physiol Biochem; 2018; 51(2):610-629. PubMed ID: 30458449
[TBL] [Abstract][Full Text] [Related]
14. Selective exosome exclusion of miR-375 by glioma cells promotes glioma progression by activating the CTGF-EGFR pathway.
Xu X; Liu Y; Li Y; Chen H; Zhang Y; Liu J; Deng S; Zheng Y; Sun X; Wang J; Chen T; Huang M; Ke Y
J Exp Clin Cancer Res; 2021 Jan; 40(1):16. PubMed ID: 33407703
[TBL] [Abstract][Full Text] [Related]
15. Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in
Peng XX; Yu R; Wu X; Wu SY; Pi C; Chen ZH; Zhang XC; Gao CY; Shao YW; Liu L; Wu YL; Zhou Q
J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31959728
[TBL] [Abstract][Full Text] [Related]
16. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis.
Shang A; Gu C; Wang W; Wang X; Sun J; Zeng B; Chen C; Chang W; Ping Y; Ji P; Wu J; Quan W; Yao Y; Zhou Y; Sun Z; Li D
Mol Cancer; 2020 Jul; 19(1):117. PubMed ID: 32713345
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin-resistant MDA-MB-231 Cell-derived Exosomes Increase the Resistance of Recipient Cells in an Exosomal miR-423-5p-dependent Manner.
Wang B; Zhang Y; Ye M; Wu J; Ma L; Chen H
Curr Drug Metab; 2019; 20(10):804-814. PubMed ID: 31424364
[TBL] [Abstract][Full Text] [Related]
18. Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2.
Wang G; Zhao W; Wang H; Qiu G; Jiang Z; Wei G; Li X
Med Sci Monit; 2019 Sep; 25():7209-7217. PubMed ID: 31553714
[TBL] [Abstract][Full Text] [Related]
19. Exosomal transfer of miR-214 mediates gefitinib resistance in non-small cell lung cancer.
Zhang Y; Li M; Hu C
Biochem Biophys Res Commun; 2018 Dec; 507(1-4):457-464. PubMed ID: 30458987
[TBL] [Abstract][Full Text] [Related]
20. Exosomal MicroRNA MiR-1246 Promotes Cell Proliferation, Invasion and Drug Resistance by Targeting CCNG2 in Breast Cancer.
Li XJ; Ren ZJ; Tang JH; Yu Q
Cell Physiol Biochem; 2017; 44(5):1741-1748. PubMed ID: 29216623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
